(HSGX) - Earnings & Price History

HSGX: - 2.08, $48.35M, -0.05 (-2.35%)

Sector: Healthcare - Industry: Biotechnology

Histogenics Corporation, a regenerative medicine company, focuses on developing and commercializing products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans. Histogenics Corporation was founded in 2000 and is headquartered in Waltham, Massachusetts.Key Statistics

Past HSGX reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-16BMO-0.451.791.781.841.751.843.37%-2.72%0.56%82.20K
2016-11-10BMO-0.492.232.442.42.012.5-1.64%▲-7.08%-8.61%168.12K
2016-08-11BMO-0.61.9991.982.041.952.043.03%-2.01%0.96%11.96K
2016-05-12BMO-0.591.81.431.391.392.06-2.80%29.50%25.87%227.32K
2016-03-10BMO-0.592.62.47012.582.42.74.45%0.78%5.26%14.00K
2016-02-26-0.59
2016-02-25-0.592.562.192.182.182.67-0.46%17.43%16.89%23.94K
2016-02-24-0.592.192.452.352.182.82-4.08%-6.81%-10.61%11.85K
2015-11-12-0.523.684.414.113.354.2-6.80%▲-10.46%-16.55%20.20K
2015-08-12-0.56.566.136.136.226.567.01%7.01%30.18K
2015-05-14BMO-0.847.888.258.257.668.28-4.48%-4.48%15.22K
2015-02-26BMO-0.669.969.6310.369.710.36437.58%-3.86%3.43%22.07K

Login | Register
Saturday Nov 17, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades